Volume 119, Issue 7

Search all Journal of Neural Transmission articles

July 2012

Special Issue: Biomarkers of neurodegeneration: beyond Alzheimer’s disease and cerebrospinal fluid

Issue Editor:

Piotr Lewczuk

16 articles in this issue

Biomarkers of neurodegeneration – not only Alzheimer’s disease and not only cerebrospinal fluid: a guest-editor’s introduction
Piotr Lewczuk
Editorial 05 June 2012 Pages: 735 - 737
α-Synuclein in human cerebrospinal fluid is principally derived from neurons of the central nervous system
Brit Mollenhauer
Ellen Trautmann
Michael G. Schlossmacher
Basic Neurosciences, Genetics and Immunology - Original Article Open access 18 March 2012 Pages: 739 - 746
CSF markers in amyotrophic lateral sclerosis
Joanna Tarasiuk
Alina Kułakowska
Piotr Lewczuk
Basic Neurosciences, Genetics and Immunology - Review article 04 May 2012 Pages: 747 - 757
Increased concentration of the CSF Tau protein and its phosphorylated form in the late juvenile metachromatic leukodystrophy form: a case report
Joanna Tarasiuk
Katarzyna Kapica-Topczewska
Piotr Lewczuk
Basic Neurosciences, Genetics and Immunology - Short communication 24 May 2012 Pages: 759 - 762
Plasmin system of Alzheimer’s disease patients: CSF analysis
Alessandro Martorana
Giulia M. Sancesario
Giuseppe Sancesario
Dementias - Original Article 14 March 2012 Pages: 763 - 769
Cerebrospinal fluid levels of Aβ42 relationship with cholinergic cortical activity in Alzheimer’s disease patients
Alessandro Martorana
Zaira Esposito
Giacomo Koch
Dementias - Original Article 09 March 2012 Pages: 771 - 778
Multidimensional plasma protein separation technique for identification of potential Alzheimer’s disease plasma biomarkers: a pilot study
Andreas Wolfram Henkel
Katharina Müller
Jens Wiltfang
Dementias - Original Article 14 March 2012 Pages: 779 - 788
Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer’s disease
Jonny Daborg
Ulf Andreasson
Henrik Zetterberg
Dementias - Original Article 10 April 2012 Pages: 789 - 797
Cerebrospinal fluid β-amyloid_1–42 correlates with rate of progression in Alzheimer’s disease
George S. Vlachos
George P. Paraskevas
Elizabeth Kapaki
Dementias - Original Article 30 March 2012 Pages: 799 - 804
Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer’s, but not in frontotemporal dementia
Mirko Bibl
Marion Gallus
Jens Wiltfang
Dementias - Original Article Open access 19 April 2012 Pages: 805 - 813
Reduced platelet amyloid precursor protein ratio (APP ratio) predicts conversion from mild cognitive impairment to Alzheimer’s disease
Isis A. Zainaghi
Leda L. Talib
Orestes V. Forlenza
Dementias - Original Article 10 May 2012 Pages: 815 - 819
Monte Carlo feature selection and rule-based models to predict Alzheimer’s disease in mild cognitive impairment
Marcin Kruczyk
Henrik Zetterberg
Mats Gunnar Andersson
Dementias - Original Article 10 May 2012 Pages: 821 - 831
A novel ARC gene polymorphism is associated with reduced risk of Alzheimer’s disease
Sara Landgren
Malin von Otter
Petronella Kettunen
Dementias - Original Article 25 May 2012 Pages: 833 - 842
Longitudinal plasma amyloid beta as a biomarker of Alzheimer’s disease
Robert A. Rissman
John Q. Trojanowski
Paul S. Aisen
Dementias - Review article 22 February 2012 Pages: 843 - 850
Clinical phenotypes and genetic biomarkers of FTLD
Daniela Galimberti
Elio Scarpini
Dementias - Review article 19 April 2012 Pages: 851 - 860
CSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD
Alessandro Stefani
Livia Brusa
Alessandro Martorana
Dementias - Review article 24 May 2012 Pages: 861 - 875

Volume 119, Issue 7

Biomarkers of neurodegeneration – not only Alzheimer’s disease and not only cerebrospinal fluid: a guest-editor’s introduction

α-Synuclein in human cerebrospinal fluid is principally derived from neurons of the central nervous system

CSF markers in amyotrophic lateral sclerosis

Increased concentration of the CSF Tau protein and its phosphorylated form in the late juvenile metachromatic leukodystrophy form: a case report

Plasmin system of Alzheimer’s disease patients: CSF analysis

Cerebrospinal fluid levels of Aβ42 relationship with cholinergic cortical activity in Alzheimer’s disease patients

Multidimensional plasma protein separation technique for identification of potential Alzheimer’s disease plasma biomarkers: a pilot study

Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer’s disease

Cerebrospinal fluid β-amyloid_1–42 correlates with rate of progression in Alzheimer’s disease

Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer’s, but not in frontotemporal dementia

Reduced platelet amyloid precursor protein ratio (APP ratio) predicts conversion from mild cognitive impairment to Alzheimer’s disease

Monte Carlo feature selection and rule-based models to predict Alzheimer’s disease in mild cognitive impairment

A novel ARC gene polymorphism is associated with reduced risk of Alzheimer’s disease

Longitudinal plasma amyloid beta as a biomarker of Alzheimer’s disease

Clinical phenotypes and genetic biomarkers of FTLD

CSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD

Navigation